Exome Asset Management »

Travere Therapeutics shares owned by Exome Asset Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 75k 38.21

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Guardant Health (GH)
Ionis Pharmaceuticals (IONS)
Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Wave Life Sciences SHS (WVE)
Vera Therapeutics Cl A (VERA)
Bridgebio Pharma (BBIO)
Anthem (ELV)
Astrazeneca Sponsored Adr
Jazz Pharmaceuticals Shs Usd (JAZZ)
Natera (NTRA)
Immunovant (IMVT)
Universal Hlth Svcs CL B (UHS)

View all positions for Exome Asset Management

Top funds holding Travere Therapeutics

Exome Asset Management
Group One Trading
Simplex Trading
Persistent Asset Partners

View all funds holding Travere Therapeutics